Literature DB >> 8169384

Intestinal mucins inhibit rotavirus replication in an oligosaccharide-dependent manner.

R H Yolken1, C Ojeh, I A Khatri, U Sajjan, J F Forstner.   

Abstract

Rotaviruses are important causes of infant morbidity and mortality worldwide. It has been previously shown that mucinous glycoproteins can inhibit rotavirus replication. However, the structure-function relationships of this inhibition have not been completely elucidated. Mucins were purified from epithelial scrapings of rat and human intestine by CsCl density-gradient ultracentrifugation and tested for the inhibition of rotavirus replication in MA-104 cells. Native human and rat intestinal mucins inhibited the replication of human and animal rotaviruses at low concentrations. Antiviral activity was most prominent in the densely glycosylated part of the rat and human mucins. Activity was retained after thiol reduction and alkylation, chloroform methanol partition, and partial removal of oligosaccharides. However, total deglycosylation of the mucins destroyed antiviral activity. Intestinal mucins from humans and other animals are potent inhibitors of rotavirus replication, and this inhibition is dependent on specific mucin-viral interactions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8169384     DOI: 10.1093/infdis/169.5.1002

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Effect of synbiotics on intestinal microflora and digestive enzyme activities in rats.

Authors:  Suh-Ching Yang; Ju-Yen Chen; Huey-Fang Shang; Ting-Ying Cheng; Su Chen Tsou; Jiun-Rong Chen
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

Review 2.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

3.  Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection.

Authors:  M Juntunen; P V Kirjavainen; A C Ouwehand; S J Salminen; E Isolauri
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

4.  Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infection.

Authors:  Max Ciarlet; Margaret E Conner; Milton J Finegold; Mary K Estes
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Porcine small intestinal epithelial cell line (IPEC-J2) of rotavirus infection as a new model for the study of innate immune responses to rotaviruses and probiotics.

Authors:  Fangning Liu; Guohua Li; Ke Wen; Tammy Bui; Dianjun Cao; Yanming Zhang; Lijuan Yuan
Journal:  Viral Immunol       Date:  2010-04       Impact factor: 2.257

6.  Lactobacillus rhamnosus GG on rotavirus-induced injury of ileal epithelium in gnotobiotic pigs.

Authors:  Fangning Liu; Guohua Li; Ke Wen; Shaoping Wu; Yongguo Zhang; Tammy Bui; Xingdong Yang; Jacob Kocher; Jun Sun; Bernard Jortner; Lijuan Yuan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-12       Impact factor: 2.839

7.  Mucin gene expression in human embryonic and fetal intestine.

Authors:  M P Buisine; L Devisme; T C Savidge; C Gespach; B Gosselin; N Porchet; J P Aubert
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

Review 8.  Potential uses of probiotics in clinical practice.

Authors:  Gregor Reid; Jana Jass; M Tom Sebulsky; John K McCormick
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

9.  Goblet cells: are they an unspecific barrier against Giardia intestinalis or a gate?

Authors:  Martha Ponce-Macotela; Angélica González-Maciel; Rafael Reynoso-Robles; Mario N Martínez-Gordillo
Journal:  Parasitol Res       Date:  2007-11-25       Impact factor: 2.289

10.  Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro.

Authors:  D R Mack; S Ahrne; L Hyde; S Wei; M A Hollingsworth
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.